These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20544508)

  • 21. Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Int J Cancer; 1992 May; 51(2):213-7. PubMed ID: 1568789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6-thioguanine resistance in a human colon carcinoma cell line with unaltered levels of hypoxanthine guanine phosphoribosyltransferase activity.
    Bemi V; Turchi G; Margotti E; Giorgelli F; Pesi R; Sgarrella F; Tozzi MG; Camici M
    Int J Cancer; 1999 Aug; 82(4):556-61. PubMed ID: 10404070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
    Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
    Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
    Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
    Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD.
    de Boer NK; van Bodegraven AA; Jharap B; de Graaf P; Mulder CJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):686-94. PubMed ID: 18043678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics of drug metabolizing enzyme: thiopurine methyl transferase phenotypes and multidrug resistance 1 gene polymorphism in inflammatory bowel disease.
    Bahrehmand F; Kiani A; Vaisi-Raygani A; Bashiri H; Zobeiri M; Tanhapour M; Pourmotabbed T
    Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):102-9. PubMed ID: 27453281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
    Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
    Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine.
    Seiderer J; Zech CJ; Reinisch W; Lukas M; Diebold J; Wrba F; Teml A; Chalupna P; Stritesky J; Schoenberg SO; Schima W; Göke B; Ochsenkühn T
    J Hepatol; 2005 Aug; 43(2):303-9. PubMed ID: 15964660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
    Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
    Aliment Pharmacol Ther; 2006 Jul; 24(2):331-42. PubMed ID: 16842460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of HPLC to study the kinetics of a branched bi-enzyme system consisting of hypoxanthine-guanine phosphoribosyltransferase and xanthine oxidase--an important biochemical system to evaluate the efficiency of the anticancer drug 6-mercaptopurine in ALL cell line.
    Kalra S; Paul MK; Balaram H; Mukhopadhyay AK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):7-14. PubMed ID: 17081813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.
    de Boer NK; Reinisch W; Teml A; van Bodegraven AA; Schwab M; Lukas M; Ochsenkühn T; Petritsch W; Knoflach P; Almer S; van der Merwe SW; Herrlinger KR; Seiderer J; Vogelsang H; Mulder CJ;
    Digestion; 2006; 73(1):25-31. PubMed ID: 16493198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study.
    Pavlidis P; Ansari A; Duley J; Oancea I; Florin T
    Inflamm Bowel Dis; 2014 Dec; 20(12):2239-46. PubMed ID: 25230165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversion in expression of hypoxanthine-guanine phosphoribosyltransferase in 6-thioguanine resistant neuroblastoma: evidence for reduced enzyme levels associated with unaltered catalytic activity.
    Skaper SD; Spector EB; Seegmiller JE
    J Cell Physiol; 1977 Aug; 92(2):275-83. PubMed ID: 18484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review.
    Meijer B; Mulder CJ; Peters GJ; van Bodegraven AA; de Boer NK
    World J Gastroenterol; 2016 Oct; 22(40):9012-9021. PubMed ID: 27833392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
    Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
    Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
    Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.
    Goldenberg BA; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2004 Sep; 99(9):1744-8. PubMed ID: 15330913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mutational assay system for L5178Y mouse lymphoma cells, using hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT) -deficiency as marker. The occurrence of a long expression time for mutations induced by X-rays and EMS.
    Knaap AG; Simons JW
    Mutat Res; 1975 Oct; 30(1):97-110. PubMed ID: 1237086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.